| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |